Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II study.
Pagani O, Sessa C, Nolè F, Crivellari D, Lombardi D, Thürlimann B, Hess D, Borner M, Bauer J, Martinelli G, Graffeo R, Zucchetti M, D'Incalci M, Goldhirsch A.
Pagani O, et al. Among authors: martinelli g.
Ann Oncol. 2000 Aug;11(8):985-91. doi: 10.1023/a:1008392927656.
Ann Oncol. 2000.
PMID: 11038035
Free article.
Clinical Trial.